Join
Live feed
·
INSIDERFilingvia Quantisnow
Cardiff Oncology Inc. logo

SEC Form 4: Erlander Mark bought $14,300 worth of shares (10,000 units at $1.43), increasing direct ownership by 69% to 24,481 units

ByQuantisnow·Wall Street's wire, on your screen.
CRDF· Cardiff Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRDF (Cardiff Oncology Inc.) and more on Quantisnow.